Bridgebio Pharma (BBIO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec8

Neil Kumar Reports on BridgeBio Pharma Common Stock Disposition

22:54

Dec5

Norwegian Bank Increases Stake in BridgeBio Pharma to 1.02%

11:17

Dec4

Legal & General Group Increased Stake in BridgeBio Pharma

10:48

Nov24

Neil Kumar reports disposal of BridgeBio Pharma common stock

23:47

Nov22

New Jersey Police and Fireman Pension System Increased Holdings in BridgeBio Pharma

10:27

Nov19

Bridgebio Pharma insiders sold $6,319,662 worth of shares

22:38

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 120.7 M, Net Income -182.74 M, EPS -0.9525

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 110.57 M, Net Income -181.9 M, EPS -0.9547

Apr29

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 116.63 M, Net Income -167.42 M, EPS -0.8804

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More